Hypera SA Company Insiders
| HYPMY Stock | USD 3.67 0.31 9.23% |
Hypera SA employs about 9 K people. The company is managed by 10 executives with a total tenure of roughly 35 years, averaging almost 3.0 years of service per executive, having 900.0 employees per reported executive. Break down of Hypera SA's management performance can provide insight into the company performance.
| Adalmario Couto Insider Investor CFO |
| Juliana Salem Insider Legal Officer |
Hypera |
Hypera SA Management Team Effectiveness
The company has return on total asset (ROA) of 0.0686 % which means that it generated a profit of $0.0686 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1626 %, meaning that it generated $0.1626 on every $100 dollars invested by stockholders. Hypera SA's management efficiency ratios could be used to measure how well Hypera SA manages its routine affairs as well as how well it operates its assets and liabilities.Hypera SA Workforce Comparison
Hypera SA is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 17,043. Hypera SA totals roughly 9,000 in number of employees claiming about 53% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33. Hypera SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hypera SA Price Series Summation is a cross summation of Hypera SA price series and its benchmark/peer.
Hypera SA Notable Stakeholders
A Hypera SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hypera SA often face trade-offs trying to please all of them. Hypera SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hypera SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Martim Mattos | CFO and Secretary | Profile | |
| Carlos Scorsi | Chief Operating officer | Profile | |
| Breno Oliveira | Chief Investor Relations Officer and Treasury Director | Profile | |
| Adalmario Couto | Investor CFO | Profile | |
| Juliana Salem | Legal Officer | Profile | |
| Hlio Segouras | Head Health | Profile | |
| Joao Aguilar | Risks Officer | Profile | |
| Mauricio Christovam | HR Officer | Profile | |
| Nelson Mello | Institutional Relations Officer, Member of the Executive Board | Profile | |
| Luiz Clavis | VP Marketing | Profile |
About Hypera SA Management Performance
The success or failure of an entity such as Hypera SA often depends on how effective the management is. Hypera SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hypera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hypera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypermarcas ADR operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9000 people.
Please note, the imprecision that can be found in Hypera SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hypera SA. Check Hypera SA's Beneish M Score to see the likelihood of Hypera SA's management manipulating its earnings.
Hypera SA Workforce Analysis
Traditionally, organizations such as Hypera SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hypera SA within its industry.Hypera SA Manpower Efficiency
Return on Hypera SA Manpower
| Revenue Per Employee | 659.7K | |
| Revenue Per Executive | 593.7M | |
| Net Income Per Employee | 134.4K | |
| Net Income Per Executive | 120.9M | |
| Working Capital Per Employee | 560.3K | |
| Working Capital Per Executive | 504.3M |
Additional Tools for Hypera Pink Sheet Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.